Directory
>
Boguslawa Wilk
Boguslawa Wilk
Executive Director, Analytical Development | Lexicon Pharmaceuticals, Inc.
United States
Boguslawa Wilk
Summary
Boguslawa Wilk is an accomplished Executive Director in Analytical Development at Lexicon Pharmaceuticals, bringing over two decades of experience in the pharmaceutical industry. With a strong foundation in analytical chemistry, she has a proven track record of leading teams through complex drug development processes from early stages to commercialization. Her expertise encompasses a wide array of analytical techniques including HPLC and mass spectrometry, as well as regulatory compliance and quality assurance. Boguslawa is recognized for her strategic thinking and has been instrumental in mentoring the next generation of scientists. She has worked closely with regulatory bodies to ensure adherence to stringent guidelines, showcasing her commitment to excellence in pharmaceutical development. Her academic background includes a PhD in Organic Physical Chemistry from Rutgers University and a Master's degree from Warsaw University of Technology. Boguslawa's unique blend of scientific knowledge and leadership skills positions her as a key player in advancing pharmaceutical innovations.
Boguslawa Wilk
Work Experience
Executive Director, Analytical Development at
Lexicon Pharmaceuticals, Inc.
February 2024 - Present
Senior Director, Analytical Development at
Lexicon Pharmaceuticals, Inc.
February 2017 - February 2024
Director, Analytical Development at
LEXICON PHARMACEUTICALS
February 2014 - February 2017
Associate Director at
LEXICON PHARMACEUTICALS
January 2011 - January 2014
Associate Director at
Pfizer, Inc.
September 2009 - January 2011
Associate Director at
Wyeth Research
January 2008 - October 2009
Section Head at
Wyeth Research
January 2004 - January 2007
Principal Research Scientist I at
Wyeth Research
January 2003 - January 2004
Senior Research Scientist II at
Wyeth Research
January 1999 - January 2003
Senior Research Scientist I at
Wyeth Research
January 1996 - January 1999
Adjunct/Lecturer at
Suny At Plattsburgh
January 1994 - January 1995
Postdoctoral Research Associate and Research Assistant Professor at
University of Pittsburgh
January 1989 - January 1992
Boguslawa Wilk
Education
Rutgers University, Phd
January 1985 - January 1990
Warsaw University of Technology, M.Sc., Eng
Frequently Asked Questions about Boguslawa Wilk
What is Boguslawa Wilk email address?
Boguslawa Wilk's primary email address is *****@lexpharma.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Boguslawa Wilk work for?
Boguslawa Wilk is a Executive Director, Analytical Development at Lexicon Pharmaceuticals, Inc., a company specializing in Biological products, except diagnostic.
Where Boguslawa Wilk graduated from?
Boguslawa Wilk holds a degree in Organic Physical Chemistry from Rutgers University.
How can I directly contact Boguslawa Wilk?
To contact Boguslawa Wilk directly, you can use the email address *****@lexpharma.com. Complete contact information is available upon registration with Muraena.
Is Boguslawa Wilk an immigrant?
Yes, Boguslawa Wilk is an immigrant and currently based in United States
Who is Boguslawa Wilk?
Boguslawa Wilk is an accomplished Executive Director in Analytical Development at Lexicon Pharmaceuticals, bringing over two decades of experience in the pharmaceutical industry. With a strong foundation in analytical chemistry, she has a proven track record of leading teams through complex drug development processes from early stages to commercialization. Her expertise encompasses a wide array of analytical techniques including HPLC and mass spectrometry, as well as regulatory compliance and quality assurance. Boguslawa is recognized for her strategic thinking and has been instrumental in mentoring the next generation of scientists. She has worked closely with regulatory bodies to ensure adherence to stringent guidelines, showcasing her commitment to excellence in pharmaceutical development. Her academic background includes a PhD in Organic Physical Chemistry from Rutgers University and a Master's degree from Warsaw University of Technology. Boguslawa's unique blend of scientific knowledge and leadership skills positions her as a key player in advancing pharmaceutical innovations.
Boguslawa`s contact details
*****@lexpharma.com
Colleagues
V P, DMPK, Toxicology, Pathology
Vice President, Technical Operations
Vice President, Clinical Development
Senior Vice President & Chief Commercial Officer
VP, Business Operations and Launch Planning
Executive Director , Information Operations
Vice President, Compliance
Chief Medical Officer
Senior Vice President and General Counsel
President